PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Ely Lilly and sigilon partner to encapsulate insulin producing cells for diabetes




http://www.jdrf.org/blog/2018/04/04/new-alliance-options-managing-t1d/


So why can’t we attract a partner for this as our technology is much sturdier and avoids fibrosis?

Not sure why we aren’t developing our diabetes cure with a big pharma. This shows that encapsulation of cells producing insulin is a viable cure for diabetes. And our encapsulation system is the best. If progress is made on this sigilon technology then other big pharma should want our technology to better it. Tic tic tic.

It is well noted that stem cells producing insulin were added to the new Austrianova agreement last year to enlarge our diabetes license.